Literature DB >> 9222370

Amplification of the complete polyomavirus JC genome from brain, cerebrospinal fluid and urine using pre-PCR restriction enzyme digestion.

H T Agostini1, G L Stoner.   

Abstract

A method is described for amplification of the complete genome of the human polyomavirus JC (JCV) from progressive multifocal leukuencephalopathy (PML) brain, cerebrospinal fluid (CSF) of PML patients, and from the urine of controls without neurological disease. Efficient amplification with the 'long PCR' method is achieved with primers overlapping the single BamHI or EcoRI site following digestion of the DNA sample with the restriction enzyme BamHI or EcoRI, respectively. Cutting of the supercoiled JCV genome allows full separation of the strands during the denaturation step, and permits primer annealing to compete successfully with reassociation of the genomic DNA. With this method a single PCR amplification allows restriction fragment length polymorphism (RFLP) analysis and direct cycle sequencing of any part of the viral genome. RFLP analysis of JCV amplified from CSF has identified a new mutant sequence. Sequencing of clinical samples is useful for typing of JC virus isolates as Type 1 or Type 2 and for characterization of the JCV regulatory region as archetypal or rearranged.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9222370     DOI: 10.3109/13550289509114028

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  9 in total

1.  Phylogenetic analysis of polyomavirus BK sequences.

Authors:  Preety M Sharma; Gaurav Gupta; Abhay Vats; Ron Shapiro; Parmjeet Randhawa
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  The human fetal glial cell line SVG p12 contains infectious BK polyomavirus.

Authors:  Stian Henriksen; Garth D Tylden; Alexis Dumoulin; Biswa Nath Sharma; Hans H Hirsch; Christine Hanssen Rinaldo
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

3.  Enhancement of PCR Detection Limit by Single-Tube Restriction Endonuclease-PCR (RE-PCR).

Authors:  Sibnarayan Datta; Raghvendra Budhauliya; Soumya Chatterjee; Vijay Veer; Runu Chakravarty
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

4.  Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals.

Authors:  H T Agostini; C F Ryschkewitsch; G L Stoner
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

5.  Asian genotypes of JC virus in Native Americans and in a Pacific Island population: markers of viral evolution and human migration.

Authors:  H T Agostini; R Yanagihara; V Davis; C F Ryschkewitsch; G L Stoner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  Chinese strains (Type 7) of JC virus are afro-asiatic in origin but are phylogenetically distinct from the Mongolian and Indian strains (Type 2D) and the Korean and Japanese strains (Type 2A).

Authors:  Xiaohong Cui; Jian C Wang; Alison Deckhut; Bindu C Joseph; Philipp Eberwein; Christopher L Cubitt; Caroline F Ryschkewitsch; Hansjurgen T Agostini; Gerald L Stoner
Journal:  J Mol Evol       Date:  2004-05       Impact factor: 2.395

7.  Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

Authors:  Carl E Reid; Huo Li; Gargi Sur; Paul Carmillo; Steven Bushnell; Rich Tizard; Michele McAuliffe; Christopher Tonkin; Kenneth Simon; Susan Goelz; Paola Cinque; Leonid Gorelik; John P Carulli
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

8.  JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant.

Authors:  Xin Dang; Christian Wüthrich; Jennifer Gordon; Hirofumi Sawa; Igor J Koralnik
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

Review 9.  Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system.

Authors:  Paola Cinque; Simona Bossolasco; Ake Lundkvist
Journal:  J Clin Virol       Date:  2003-01       Impact factor: 3.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.